Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Human Genetic Evidence to Inform Clinical Development of IL-6 Signaling Inhibition for Abdominal Aortic Aneurysm.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: December 05, 2024
A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy.
Journal: Advances in therapy
Published: March 15, 2021
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis.
Journal: The New England journal of medicine
Published: February 23, 2017
Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks.
Journal: The journal of allergy and clinical immunology. In practice
Published: June 11, 2014
A phase 1 study investigating DX-2930 in healthy subjects.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: May 05, 2014
Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial.
Journal: Annals of emergency medicine
Published: January 14, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026